Przejdź do
Wybierz wielkość
| Do Państwa/SKU | Dostępność | Cena netto |
|---|---|---|
25 mg | Skontaktuj się z Obsługą Klienta, aby uzyskać informacje na temat dostępności | 6630,00 zł |
Informacje o tej pozycji
6630,00 zł
grade
pharmaceutical primary standard
agency
USP
API family
dalfampridine
manufacturer/tradename
USP
availability
not available in (Sales restrictions may apply)
application(s)
pharmaceutical
format
neat
General description
Analysis Note
Other Notes
1 of 1
Ta pozycja | |||
|---|---|---|---|
| description United States Pharmacopeia (USP) Reference Standard | description United States Pharmacopeia (USP) Reference Standard | description United States Pharmacopeia (USP) Reference Standard | description United States Pharmacopeia (USP) Reference Standard |
| grade pharmaceutical primary standard | grade pharmaceutical primary standard | grade pharmaceutical primary standard | grade pharmaceutical primary standard |
| manufacturer/tradename USP | manufacturer/tradename USP | manufacturer/tradename USP | manufacturer/tradename USP |
| application(s) pharmaceutical | application(s) pharmaceutical | application(s) pharmaceutical | application(s) (Pharmaceutical small molecule) |
| format neat | format neat | format neat | format neat |
| API family dalfampridine | API family diltiazem | API family dalfampridine | API family brimonidine |
| availability not available in (Sales restrictions may apply) | availability - | availability - | availability not available in (Sales restrictions may apply) |
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 3 Oral
Klasa składowania
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Wybierz jedną z najnowszych wersji:
Masz już ten produkt?
Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.


